About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2025 Clareo Health. All rights reserved.

Not Yet RecruitingPhase 2

Evaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting

A Multicenter, Randomized, Double-blind, Active-Controlled Dose-Finding Study of HSK21542 Injection for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV)

NCT06593782•First Affiliated Hospital of Wenzhou Medical University

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Nausea and Vomiting, Chemotherapy-Induced

Interventions

HSK21542

HSK21542

+1 more

Key Dates

Start Date

September 16, 2024

Primary Completion Date

June 11, 2025

Completion Date

September 1, 2025

Last Updated

September 19, 2024

Related Studies

COMPLETEDPhase 1

A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

NCT00405080

Nausea and Vomiting, Chemotherapy-Induced

COMPLETEDPhase 1

A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

NCT00404274

Nausea and Vomiting, Chemotherapy-Induced

COMPLETEDPhase 1

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

NCT00511823

Nausea and Vomiting, Chemotherapy-Induced

COMPLETEDPhase 3

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

NCT00366834

VomitingNausea+1 more

Contacts

Shen Xian

CONTACT

13968888872 13968888872@163.com

Sponsors

Lead Sponsor

First Affiliated Hospital of Wenzhou Medical University

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 19, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions